127 related articles for article (PubMed ID: 38858670)
1. Serum concentrations of legacy, alternative, and precursor per- and polyfluoroalkyl substances: a descriptive analysis of adult female participants in the MIREC-ENDO study.
Borghese MM; Ward A; MacPherson S; Manz KE; Atlas E; Fisher M; Arbuckle TE; Braun JM; Bouchard MF; Ashley-Martin J
Environ Health; 2024 Jun; 23(1):55. PubMed ID: 38858670
[TBL] [Abstract][Full Text] [Related]
2. Correlates of plasma concentrations of per- and poly-fluoroalkyl substances among reproductive-aged Black women.
Wise LA; Wesselink AK; Schildroth S; Calafat AM; Bethea TN; Geller RJ; Coleman CM; Fruh V; Claus Henn B; Botelho JC; Harmon QE; Thirkill M; Wegienka GR; Baird DD
Environ Res; 2022 Jan; 203():111860. PubMed ID: 34403666
[TBL] [Abstract][Full Text] [Related]
3. An investigation of 3M Cordova, IL production worker's per- and polyfluoroalkyl substances biomonitoring results and mortality experience.
Andres KL; Olsen GW; Krisko RM; Nunnally MC; Boeding RR; Leniek KL; Taiwo OA
Int J Hyg Environ Health; 2024 Mar; 256():114321. PubMed ID: 38244249
[TBL] [Abstract][Full Text] [Related]
4. Longitudinal trends in perfluoroalkyl and polyfluoroalkyl substances among multiethnic midlife women from 1999 to 2011: The Study of Women's Health Across the Nation.
Ding N; Harlow SD; Batterman S; Mukherjee B; Park SK
Environ Int; 2020 Feb; 135():105381. PubMed ID: 31841808
[TBL] [Abstract][Full Text] [Related]
5. Human biomonitoring of per- and polyfluoroalkyl substances in German blood plasma samples from 1982 to 2019.
Göckener B; Weber T; Rüdel H; Bücking M; Kolossa-Gehring M
Environ Int; 2020 Dec; 145():106123. PubMed ID: 32949877
[TBL] [Abstract][Full Text] [Related]
6. Per- and polyfluoroalkyl substances (PFAS) in Australia: Current levels and estimated population reference values for selected compounds.
Toms LML; Bräunig J; Vijayasarathy S; Phillips S; Hobson P; Aylward LL; Kirk MD; Mueller JF
Int J Hyg Environ Health; 2019 Apr; 222(3):387-394. PubMed ID: 30898527
[TBL] [Abstract][Full Text] [Related]
7. Variability of perfluoroalkyl substance concentrations in pregnant women by socio-demographic and dietary factors in a Spanish birth cohort.
Manzano-Salgado CB; Casas M; Lopez-Espinosa MJ; Ballester F; Martinez D; Ibarluzea J; Santa-Marina L; Schettgen T; Vioque J; Sunyer J; Vrijheid M
Environ Int; 2016; 92-93():357-65. PubMed ID: 27132161
[TBL] [Abstract][Full Text] [Related]
8. Biomonitoring of perfluoroalkyl and polyfluoroalkyl substances (PFAS) from the Survey of the Health of Wisconsin (SHOW) 2014-2016 and comparison with the National Health and Nutrition Examination Survey (NHANES).
Schultz AA; Stanton N; Shelton B; Pomazal R; Lange MA; Irving R; Meiman J; Malecki KC
J Expo Sci Environ Epidemiol; 2023 Sep; 33(5):766-777. PubMed ID: 37580384
[TBL] [Abstract][Full Text] [Related]
9. Prenatal perfluoroalkyl substances and newborn anogenital distance in a Canadian cohort.
Arbuckle TE; MacPherson S; Foster WG; Sathyanarayana S; Fisher M; Monnier P; Lanphear B; Muckle G; Fraser WD
Reprod Toxicol; 2020 Jun; 94():31-39. PubMed ID: 32283250
[TBL] [Abstract][Full Text] [Related]
10. Demographic, life-style and physiological determinants of serum per- and polyfluoroalkyl substance (PFAS) concentrations in a national cross-sectional survey of Swedish adolescents.
Nyström J; Benskin JP; Plassmann M; Sandblom O; Glynn A; Lampa E; Gyllenhammar I; Moraeus L; Lignell S
Environ Res; 2022 May; 208():112674. PubMed ID: 34998808
[TBL] [Abstract][Full Text] [Related]
11. Biomarkers of poly- and perfluoroalkyl substances (PFAS) in Sub-Arctic and Arctic communities in Canada.
Garcia-Barrios J; Drysdale M; Ratelle M; Gaudreau É; LeBlanc A; Gamberg M; Laird BD
Int J Hyg Environ Health; 2021 Jun; 235():113754. PubMed ID: 33984600
[TBL] [Abstract][Full Text] [Related]
12. Serum concentrations of legacy and emerging per- and polyfluoroalkyl substances in the Anniston Community Health Surveys (ACHS I and ACHS II).
Petriello MC; Mottaleb MA; Serio TC; Balyan B; Cave MC; Pavuk M; Birnbaum LS; Morris AJ
Environ Int; 2022 Jan; 158():106907. PubMed ID: 34763231
[TBL] [Abstract][Full Text] [Related]
13. Prenatal exposure to legacy PFAS and neurodevelopment in preschool-aged Canadian children: The MIREC cohort.
Goodman CV; Till C; Green R; El-Sabbagh J; Arbuckle TE; Hornung R; Lanphear B; Seguin JR; Booij L; Fisher M; Muckle G; Bouchard MF; Ashley-Martin J
Neurotoxicol Teratol; 2023; 98():107181. PubMed ID: 37178772
[TBL] [Abstract][Full Text] [Related]
14. Levels of per- and polyfluoroalkyl substances (PFAS) in Norwegian children stratified by age and sex - Data from the Bergen Growth Study 2.
Forthun IH; Roelants M; Haug LS; Knutsen HK; Schell LM; Jugessur A; Bjerknes R; Sabaredzovic A; Bruserud IS; Juliusson PB
Int J Hyg Environ Health; 2023 Jul; 252():114199. PubMed ID: 37295275
[TBL] [Abstract][Full Text] [Related]
15. Legacy and alternative per- and polyfluoroalkyl substances in the U.S. general population: Paired serum-urine data from the 2013-2014 National Health and Nutrition Examination Survey.
Calafat AM; Kato K; Hubbard K; Jia T; Botelho JC; Wong LY
Environ Int; 2019 Oct; 131():105048. PubMed ID: 31376596
[TBL] [Abstract][Full Text] [Related]
16. Biomonitoring of emerging contaminants, perfluoroalkyl and polyfluoroalkyl substances (PFAS), in New Jersey adults in 2016-2018.
Yu CH; Riker CD; Lu SE; Fan ZT
Int J Hyg Environ Health; 2020 Jan; 223(1):34-44. PubMed ID: 31679856
[TBL] [Abstract][Full Text] [Related]
17. Per- and polyfluoroalkyl substances in human serum and urine samples from a residentially exposed community.
Worley RR; Moore SM; Tierney BC; Ye X; Calafat AM; Campbell S; Woudneh MB; Fisher J
Environ Int; 2017 Sep; 106():135-143. PubMed ID: 28645013
[TBL] [Abstract][Full Text] [Related]
18. Per- and polyfluoroalkyl substances in sera from children 3 to 11 years of age participating in the National Health and Nutrition Examination Survey 2013-2014.
Ye X; Kato K; Wong LY; Jia T; Kalathil A; Latremouille J; Calafat AM
Int J Hyg Environ Health; 2018 Jan; 221(1):9-16. PubMed ID: 28993126
[TBL] [Abstract][Full Text] [Related]
19. Maternal serum concentrations of per- and polyfluoroalkyl substances and their predictors in years with reduced production and use.
Berg V; Nøst TH; Huber S; Rylander C; Hansen S; Veyhe AS; Fuskevåg OM; Odland JØ; Sandanger TM
Environ Int; 2014 Aug; 69():58-66. PubMed ID: 24815340
[TBL] [Abstract][Full Text] [Related]
20. Prenatal exposure to per- and polyfluoroalkyl substances (PFAS) and associations with hypertensive disorders of pregnancy in the Atlanta African American Maternal-Child cohort.
Thompson M; Eatman JA; Dunlop AL; Barr DB; Kannan K; Corwin EJ; Ryan PB; Panuwet P; Yakimavets V; Taibl KR; Tan Y; Liang D; Eick SM
Chemosphere; 2024 Jun; 357():142052. PubMed ID: 38631500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
